These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30275094)

  • 21. Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs.
    Suzuki F; Suzuki Y; Hosaka T; Sezaki H; Akuta N; Fujiyama S; Kawamura Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Mineta R; Suzuki Y; Kumada H
    J Gastroenterol; 2017 May; 52(5):641-651. PubMed ID: 27699721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 23. Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus.
    Hyun MH; Lee YS; Kim JH; Je JH; Yoo YJ; Yeon JE; Byun KS
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1493-1505. PubMed ID: 28436552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.
    Salvadori N; Fan B; Teeyasoontranon W; Ngo-Giang-Huong N; Phanomcheong S; Luvira A; Puangsombat A; Suwannarat A; Srirompotong U; Putiyanun C; Cressey TR; Decker L; Khamduang W; Harrison L; Tierney C; Shepherd JA; Kourtis AP; Bulterys M; Siberry GK; Jourdain G
    Clin Infect Dis; 2019 Jun; 69(1):144-146. PubMed ID: 30924492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV.
    Pan CQ; Chang TT; Bae SH; Brunetto M; Seto WK; Coffin CS; Tan SK; Mo S; Flaherty JF; Gaggar A; Nguyen MH; Çelen MK; Thompson A; Gane EJ
    PLoS One; 2021; 16(5):e0251552. PubMed ID: 33984038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenofovir disoproxil fumarate for prevention of mother-to-child transmission of hepatitis B virus: A systematic review and meta-analysis of randomised control trials.
    Zeleke ED; Assefa DG; Joseph M; Bekele D; Tesfahunei HA; Getachew E; Manyazewal T
    Rev Med Virol; 2021 Sep; 31(5):1-16. PubMed ID: 33483986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
    ; Dionne-Odom J; Tita AT; Silverman NS
    Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load.
    Chen JZ; Liao ZW; Huang FL; Su RK; Wang WB; Cheng XY; Chen JQ; Liu JQ; Huang Z
    Sci Rep; 2017 Jun; 7(1):4132. PubMed ID: 28646142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load.
    Wang M; Ran R; Zhu Y; Zhang H
    Int J Gynaecol Obstet; 2023 Feb; 160(2):646-652. PubMed ID: 35816243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naïve chronic hepatitis B: A case report and review of the literature.
    Cho WH; Lee HJ; Bang KB; Kim SB; Song IH
    World J Gastroenterol; 2018 May; 24(17):1919-1924. PubMed ID: 29740207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy Outcome of Women with Chronic Hepatitis B who Discontinued Antiviral Treatment before or in the Early Pregnancy.
    Gao X; Duan X; Cai H; Hu Y; Liu M; Kang K; Zhou M; Fu D; Yi W
    Int J Med Sci; 2020; 17(2):170-175. PubMed ID: 32038100
    [No Abstract]   [Full Text] [Related]  

  • 32. Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial.
    Yim HJ; Kim IH; Suh SJ; Jung YK; Kim JH; Seo YS; Yeon JE; Kim CW; Kwon SY; Park SH; Lee MS; Um SH; Byun KS
    J Viral Hepat; 2018 Nov; 25(11):1321-1330. PubMed ID: 29772084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impact of cessation of antiviral therapy at delivery on postpartum liver function in mothers with chronic hepatitis B virus infection].
    Guo HJ; Gao YF; Liu HY; He HT; Huang MT; Cai DC; Liao DD; Li JN; Yin XR; Liu ZH; Hu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):112-117. PubMed ID: 30818915
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them.
    Seo KI; Bae SH; Sung PS; Park CH; Lee HL; Kim HY; Kim HJ; Jang BH; Jang JW; Yoon SK; Choi JY; Park IY; Lee J; Lee HS; Kim SJ; Kwon JH; Chang UI; Kim CW; Jo SH; Lee Y; Tekle F; Kim JH
    Clin Mol Hepatol; 2018 Dec; 24(4):374-383. PubMed ID: 29940720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy.
    Bierhoff M; Nelson KE; Guo N; Jia Y; Angkurawaranon C; Jittamala P; Carrara V; Watthanaworawit W; Ling C; Tongprasert F; van Vugt M; Rijken M; Nosten F; McGready R; Ehrhardt S; Thio CL
    BMJ Open; 2020 Sep; 10(9):e038123. PubMed ID: 32928858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenofovir alters the immune microenvironment of pregnant women with hepatitis B virus infection: Evidence from single-cell RNA sequencing.
    Li X; Wang HY; Gao F; Guo FF; Wang XN; Pan YX; Bai GQ
    Int Immunopharmacol; 2023 Jun; 119():110245. PubMed ID: 37163920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
    Sellier PO; Maylin S; Berçot B; Chopin D; Lopes A; Simoneau G; Evans J; Delcey V; Bénifla JL; Simon F; Bergmann JF
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study.
    Berg T; Simon KG; Mauss S; Schott E; Heyne R; Klass DM; Eisenbach C; Welzel TM; Zachoval R; Felten G; Schulze-Zur-Wiesch J; Cornberg M; Op den Brouw ML; Jump B; Reiser H; Gallo L; Warger T; Petersen J;
    J Hepatol; 2017 Nov; 67(5):918-924. PubMed ID: 28736139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
    Hu YH; Liu M; Yi W; Cao YJ; Cai HD
    World J Gastroenterol; 2015 Feb; 21(8):2504-9. PubMed ID: 25741161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral therapy for hepatitis B virus during second pregnancies.
    Wakano Y; Sugiura T; Endo T; Ito K; Suzuki M; Tajiri H; Tanaka Y; Saitoh S
    J Obstet Gynaecol Res; 2018 Mar; 44(3):566-569. PubMed ID: 29227001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.